Organ Tissue Donation and Transplantation (OTDT)

On 20 May 2020, the law around organ donation in England was changed to help save and improve more lives. 

How does the opt out system work?

The opt out system works on the understanding that all adults agree to become organ donors when they die, unless they have made it known that they do not wish to donate. 

If you have not recorded an organ donation decision and you are not in one of the excluded groups, it will be considered that you agree to donate your organs, when you die. 

You may hear this system referred to as the opt out system, deemed consent, presumed consent or Max and Keira's Law. 

You can still choose whether or not you want to be an organ donor when you die by registering your decision and telling your family. Your faith, beliefs and culture will continue to be respected.

Who is affected?

The opt out system applies to everyone in England, except for those who are part of what are called excluded groups. 

Excluded groups are:

  • Those under the age of 18
  • People who lack the mental capacity to understand the new arrangements and take the necessary action
  • Visitors to England, and those not living here voluntarily
  • People who have lived in England for less than 12 months before their death

Find out more here.

Advisory Groups

The Advisory Groups are the key fora for clinicians and scientists to meet with representatives from NHS Blood and Transplant (NHSBT), commissioners and Departments of Health and others to review and develop policies, assess outcomes, and work with partners and stakeholders to improve outcomes for patients. The structure and role of the Advisory Groups has recently been reviewed and recommendations made from which changes will be implemented. The Chairs, who are all elected with independent input, meet at the Chairs of the Advisory Groups Committee. The Advisory Groups report to the Organ Donation and Transplantation (ODT) Senior Management Team.

The solid organ advisory groups discuss:

  • Donation activity
  • Transplant activity
  • Waiting times
  • Equity of access
  • Selection and organ allocation
  • Transplant outcomes and research

More information of Advisory Groups can be found here.